Patient satisfaction with hair regrowth in a study of ritlecitinib: a plain language summary.
作者信息
Sinclair Rodney, Law Ernest H, Zhang Xingqi, Zhang Fan, Napatalung Lynne, Zwillich Samuel H, King Brett, Mesinkovska Natasha
机构信息
aSinclair Dermatology, Melbourne, VIC, Australia.
bPfizer Inc, New York, NY, USA.
出版信息
Immunotherapy. 2025 Jun;17(8):541-550. doi: 10.1080/1750743X.2025.2513849. Epub 2025 Jun 26.
Abstract
摘要
相似文献
1
Patient satisfaction with hair regrowth in a study of ritlecitinib: a plain language summary.在一项关于利特昔替尼的研究中患者对毛发再生的满意度：通俗易懂的总结
Immunotherapy. 2025 Jun;17(8):541-550. doi: 10.1080/1750743X.2025.2513849. Epub 2025 Jun 26.
2
Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata.口服酪氨酸激酶3/肝细胞癌中表达的酪氨酸激酶家族激酶抑制剂芦可替尼24个月的疗效和安全性：斑秃的ALLEGRO IIb/III期和长期III期临床研究的综合分析
Br J Dermatol. 2025 Jan 24;192(2):215-227. doi: 10.1093/bjd/ljae365.
3
Adapting Safety Plans for Autistic Adults with Involvement from the Autism Community.在自闭症群体的参与下为成年自闭症患者调整安全计划。
Autism Adulthood. 2025 May 28;7(3):293-302. doi: 10.1089/aut.2023.0124. eCollection 2025 Jun.
4
Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial.使用芦可替尼治疗的斑秃患者中，通过斑秃患者优先结局工具测量的患者报告的脱发情况及其影响：ALLEGRO 2b/3期随机临床试验
Am J Clin Dermatol. 2025 Jan;26(1):109-119. doi: 10.1007/s40257-024-00899-4. Epub 2024 Oct 23.
5
Treatments for alopecia areata: a network meta-analysis.斑秃治疗方法的网状荟萃分析。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013719. doi: 10.1002/14651858.CD013719.pub2.
6
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂（GLP-1 RAs）减肥效果的网状Meta分析的数量、质量及结果：一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病：网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Tirzepatide and health-related quality of life in adults with obesity or overweight: Results from the SURMOUNT-3 phase 3 randomized trial.替尔泊肽与肥胖或超重成人的健康相关生活质量：SURMOUNT-3 三期随机试验结果
Diabetes Obes Metab. 2025 May 14. doi: 10.1111/dom.16463.
9
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.疾病轨迹的生活经历、治疗负担和社会不平等如何影响服务使用者和照顾者参与健康和社会护理：一项基于理论的定性证据综合分析
Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159.
10
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎：系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
Zotero 插件